Artigos com autorizações de acesso público - Renumathy DhanasekaranSaiba mais
4 artigos não disponíveis publicamente
Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma
P Guo, Y Wang, C Dai, C Tao, F Wu, X Xie, H Yu, Q Zhu, J Li, L Ye, F Yu, ...
Oncogene 37 (9), 1220-1236, 2018
Autorizações: National Natural Science Foundation of China
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
R Dhanasekaran, H Suzuki, L Lemaitre, N Kubota, Y Hoshida
Hepatology 81 (3), 1038-1057, 2025
Autorizações: European Commission
Genomic Landscape of HCC
N Adeniji, R Dhanasekaran
Current Hepatology Reports 19, 448-461, 2020
Autorizações: US National Institutes of Health
Response to Houlihanet al.
R Dhanasekaran, HS Kim
Official journal of the American College of Gastroenterology| ACG 108 (11), 1807, 2013
Autorizações: UK Medical Research Council, Wellcome Trust
84 artigos disponíveis publicamente
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Autorizações: US Department of Defense, US National Institutes of Health
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
Autorizações: US Department of Defense, US National Institutes of Health
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Autorizações: US National Institutes of Health
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Autorizações: US National Institutes of Health
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
Autorizações: US National Institutes of Health
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
Autorizações: US National Institutes of Health, US Department of Veterans Affairs
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
Autorizações: US National Institutes of Health, US Department of Veterans Affairs …
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
Autorizações: US Department of Defense, US National Institutes of Health
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
Autorizações: US National Institutes of Health
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
Autorizações: US National Science Foundation, US National Institutes of Health
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
Autorizações: US National Institutes of Health
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
Autorizações: US National Institutes of Health, Federal Ministry of Education and Research …
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
Autorizações: US National Institutes of Health
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines
K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ...
Cell systems 6 (3), 271-281. e7, 2018
Autorizações: US National Institutes of Health
A comprehensive pan-cancer molecular study of gynecologic and breast cancers
AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ...
Cancer cell 33 (4), 690-705. e9, 2018
Autorizações: US National Institutes of Health
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
R Dhanasekaran, A Deutzmann, WD Mahauad-Fernandez, AS Hansen, ...
Nature reviews Clinical oncology 19 (1), 23-36, 2022
Autorizações: US National Institutes of Health, Lymphoma Research Foundation, USA
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador